Skip to search formSkip to main contentSkip to account menu

arglecin

Known as: 6-(3-guanidino-propyl)-3-isobutyl-2-(1H)- pyrazinone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
To date, studies describing myxobacterial secondary metabolites have been relatively scarce in comparison to those addressing… 
2010
2010
The invention provides novel substituted 6-arylamino pyridone sulfonamides and 6 arylamino pyrazinone sulfonamides represented by… 
2008
2008
Akt kinases are attractive targets for small molecule drug discovery because of their key role in tumor cell survival… 
Highly Cited
2004
Highly Cited
2004
In an effort to discover potent, clinically useful thrombin inhibitors, a rapid analogue synthetic approach was used to explore… 
1999
1999
Cyclization of (S,S)-alpha-[(1-phenylethyl)amino]-alpha-(2-iodophenyl)acetonitrile with (COCl)(2) in toluene or chlorobenzene… 
1977
1977
The requirements for maximum production of arglecin, 3-isobuty1-6-(3-guanidinopropyl)-2(1H)pyrazinone, by Streptomyces… 
1972
1972
1971
1971
A new streptomycete metabolite named arglecin was isolated from the culture filtrates of the strains KA57-AG3, KB59-M1 and the…